Study Site 204 — Fremont, California

Study Site 204 is a clinical research site located in Fremont, California, United States 94538.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Study Site 204 has participated in 4 clinical trials.

Therapeutic areas: Pruritus, Psoriasis, Prurigo Nodularis.

Sponsors: Vyne Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fremont

Browse all research sites in California · View every site in Fremont

• Washington Hospital
• California Cardiovascular/Washington Hospital
• California Cardiovascular Consultants/ Washington Hospital
• Washington Hospital Healthcare System
• UCSF Washington Hospital Cancer Center/ Washington Hospital Healthcare System
• St. Rose Hospital
• Washington Township Hospital
• Kaiser Permanente Fremont
• Center for Dermatology Clinical Research
• Palo Alto Medical Foundation-Fremont
• Valley Medical Oncology Consultants-Fremont
• Mission Cardiovascular Research Institute

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 204?

Study Site 204 has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 204 conducted?

Study Site 204 has 4 clinical trials on record. Their work covers Pruritus, Psoriasis, Prurigo Nodularis.

Is Study Site 204 accredited by Crixeo Clinical Trials?

Study Site 204 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 204?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.